Kim, H.W.; Park, J.E.; Baek, M.; Kim, H.; Ji, H.W.; Yun, S.H.; Jeong, D.; Ham, J.; Park, S.; Lu, X.;
et al. Matrix Metalloproteinase-1 (MMP1) Upregulation through Promoter Hypomethylation Enhances Tamoxifen Resistance in Breast Cancer. Cancers 2022, 14, 1232.
https://doi.org/10.3390/cancers14051232
AMA Style
Kim HW, Park JE, Baek M, Kim H, Ji HW, Yun SH, Jeong D, Ham J, Park S, Lu X,
et al. Matrix Metalloproteinase-1 (MMP1) Upregulation through Promoter Hypomethylation Enhances Tamoxifen Resistance in Breast Cancer. Cancers. 2022; 14(5):1232.
https://doi.org/10.3390/cancers14051232
Chicago/Turabian Style
Kim, Hyeon Woo, Jae Eun Park, Minjae Baek, Heejoo Kim, Hwee Won Ji, Sung Hwan Yun, Dawoon Jeong, Juyeon Ham, Sungbin Park, Xinpei Lu,
and et al. 2022. "Matrix Metalloproteinase-1 (MMP1) Upregulation through Promoter Hypomethylation Enhances Tamoxifen Resistance in Breast Cancer" Cancers 14, no. 5: 1232.
https://doi.org/10.3390/cancers14051232
APA Style
Kim, H. W., Park, J. E., Baek, M., Kim, H., Ji, H. W., Yun, S. H., Jeong, D., Ham, J., Park, S., Lu, X., Kang, H.-S., & Kim, S. J.
(2022). Matrix Metalloproteinase-1 (MMP1) Upregulation through Promoter Hypomethylation Enhances Tamoxifen Resistance in Breast Cancer. Cancers, 14(5), 1232.
https://doi.org/10.3390/cancers14051232